natgillin/translations-raw huggingface dataset:
Among in vitro susceptibility data for M. gallisepticum, a new MIC survey of lincomycin-spectinomycin (1:2 ratio) was carried out on 60 isolates, and showed a MIC range of [0.25:0.5 - 8:16 µg/ml], and MIC50/MIC90 values of 0.5:1 and 2:4 µg/ml, respectively. 
Glede podatkov o občutljivosti in vitro za M. gallisepticum se je izvedla nova raziskava MIK za linkomicin-spektinomicin (v razmerju 1 : 2) s 60 izolati, ki je pokazala razpon MIK [0,25 : 0,58 : 16 µg/ml] in vrednosti MIC50 0,5 : 1 ter MIC90 2 : 4 µg/ml.
June http://www.who.int/foodsafety/foodborne_disease/AGISAR_2009_report_final.pdf?ua=1 
3 Poročilo Report of the first meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR), 15-19 June 2009. http://www.who.int/foodsafety/foodborne_disease/AGISAR_2009_report_final.pdf?ua=1
For the treatment and prevention of dysentery caused by Brachyspira hyodysenteria and for the treatment and prevention of porcine proliferative enteropathy (ileitis) caused by Lawsonia intracellularis, and associated enteric pathogens (Escherichia coli). 
Za zdravljenje in preprečevanje prašičje dizenterije, ki jo povzroča Brachyspira hyodysenteriae, za zdravljenje in preprečevanje prašiščje proliferativne enteropatije (ileitisa), ki ga povzroča Lawsonia intracellularis in povezanih črevesnih patogenov (Escherichia coli).
4.8 Interaction with other medicinal products and other forms of interaction 
4.8 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Mešanju z drugimi zdravili se je treba praviloma izogibati.
It was the only available trial where the 50 mg/kg bw dose was firmly shown to be beneficial in a treatment context, although the challenge was rather mild (e.g. no mortality was recorded); 
To je bilo edino razpoložljivo preskušanje, v katerem so jasno pokazali, da je odmerek 50 mg/kg telesne mase koristen v sklopu zdravljenja, čeprav je bila provokacija precej blaga (npr. zabeležili niso nobenega primera umrljivosti).
* A detrimental shift to the use of other molecules considered as more important to public health (e.g. fluoroquinolones) might occur in case the product is withdrawn in chickens. 
• Če se zdravilo za uporabo pri piščancih ukine, lahko pride do škodljivega prehoda na uporabo drugih molekul, za katere menijo, da so pomembnejše za javno zdravje (npr. fluorokinoloni).
The combination was superior to lincomycin alone. 
Kombinacija je bila boljša kot samostojni linkomicin.
Chickens: 16.65 mg lincomycin and 33.35 mg spectinomycin/kg bw/day, for 7 days. 
Piščanci: 16,65 mg linkomicina in 33,35 mg spektinomicina/kg telesne teže/dan, za čas zdravljenja 7 dni.
Excipients: Sodium benzoate, lactose. 
Pomožne snovi: Natrijev benzoat, laktoza monohidrat.
Poultry (broilers) 
Piščanci (brojlerji)
Lincomycin resistance is widespread in B. hyodysenteriae and may lead to clinical treatment failure. 
Razširjena odpornost na linkomicin pri B. Hyodysenteriae ima lahko za posledico neuspešno klinično zdravljenje.
It is mainly active against Gram-positive bacteria and obligate anaerobes, and against mycoplasmas. 
Navadno učinkuje proti grampozitivnim bakterijam, obligatnim anaerobom in mikoplazmam.
Personal protective equipment consisting of approved dust masks (either a disposable half mask respirator conforming to European Standard EN149 or a non-disposable respirator conforming to European Standard EN 140 with a filter EN 143), gloves and safety glasses should be worn when handling and mixing the product. 
Ob ravnanju in mešanju izdelka je treba nositi osebno zaščitno opremo, ki sestoji iz priporočenih mask za prah (ali dihalno polmasko za enkratno uporabo, ki ustreza evropskemu standardu EN149 ali dihalno masko za veečkratno uporabo, ki ustreza evropskemu standardu EN140 s filtrom EN143), rokavic in zaščitnih očal.
NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 222 mg/g + 444.7 mg/g powder for use in drinking water lincomycin (as lincomycin hydrochloride)/spectinomycin (as spectinomycin sulphate). 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI <Izmišljeno ime> 222 mg/g + 444,7 mg/g prašek za dajanje v vodo za pitje linkomicin (kot linkomicinijev klorid)/spektinomicin (kot spektinomicinijev sulfat)
Double LDPE bag containing 4.5 kg powder inside a tamper evident polypropylene tub with a polypropylene lid. 
Dvojna LDPE vreča v vedru iz polipropilena z zaščitnim pokrovom iz polipropilena vsebuje 4,5 kg praška.
Also, information as to widespread decreased susceptibility in B. hyodysenteriae and as to the bimodal distribution in E. coli should be added to section 5.1. 
Prav tako je treba v poglavje 5.1 Farmakodinamične lastnosti dodati informacije o široko razširjeni zmanjšani občutljivosti B. hyodysenteriae in bimodalni porazdelitvi E. coli.
Chickens: Meat and offal: 5 days. 
Piščanci: Meso in organi: 5 dni.
In pigs, lincomycin is rapidly absorbed following oral administration. 
Po peroralnem dajanju se linkomicin pri prašičih hitro absorbira.
Whereas * the CVMP considered the scope of the referral was the harmonisation of the summary of product characteristics, labelling and package leaflet; * the CVMP reviewed the summary of product characteristics, labelling and package leaflet proposed by the marketing authorisation holders and considered all the overall submitted data; 
• CVMP je pregledal povzetek glavnih značilnosti zdravila, označevanje in navodilo za uporabo, ki jih predlagajo imetniki dovoljenj za promet, in upošteval vse predložene podatke;
Poultry: For dosing via the drinking water. 
Perutnina: za odmerjanje v vodo za pitje.
Pigs and poultry (nonlayers) 
Prašiči in perutnina (nenesnice)
10,000 x [daily water consumption per animal (L)] average body weight of one pig (kg) In pigs 150 g of the veterinary medicinal product corresponds to the dose for 10,000 kg of body weight per day. 
povprečna telesna teža enega prašiča (kg) Pri prašičih 150 g zdravila za uporabo v veterinarski medicini ustreza odmerku za 10000 kg telesne teže na dan.
In E. coli, a significant part of the strains show high MIC values (minimum inhibitory concentrations) against the lincomycin-spectinomycin combination and may be clinically resistant, although no breakpoint is defined. 
Velik del sevov E. coli kaže visoke vrednosti MIK (minimalne inhibitorne koncentracije) proti kombinaciji linkomicin - spektinomicin in je lahko klinično odporen, čeprav mejna vrednost ni določena.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION For use in drinking water. 
ODMERKI ZA POSAMEZNE ŽIVALSKE VRSTE TER POT(I) IN NAČIN UPORABE
Lithuania Zoetis Belgium SA Rue Laid Burniat 1 
Luksemburg Zoetis Belgium SA Rue Laid Burniat 1
Grounds for amendment of the summary of product characteristics, labelling and package leaflet 
Razlogi za spremembo povzetka glavnih značilnosti zdravila, označevanja in navodila za uporabo
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER To be completed nationally 
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Podatke je treba dopolniti v posameznih državah
For the treatment and prevention of chronic respiratory disease (CRD) caused by Mycoplasma gallisepticum and Escherichia coli, and associated with a low mortality rate. 
Za zdravljenje in preprečevanje kronične respiratorne bolezni (CRD), ki ju povzročata Mycoplasma gallisepticum in Escherichia coli in je povezana z nizko stopnjo umrljivosti.
In a newly provided GCP challenge study the product used at 50 mg/kg bw/day for 7 days was shown to be effective in reducing clinical signs, lesions and bacteriological re-isolation associated to E. coli and/or M. gallisepticum experimental infection in chickens, although the bacterial re-isolation rate was high, with a non-statistically significant reduction for E. coli, and the MIC of the infective strains was low when compared to most field strains. 
V novo predloženi, z DKP skladni provokacijski študiji zdravljenja z zdravilom v odmerku 50 mg/kg telesne mase/dan, ki je trajalo 7 dni, so pokazali, da je učinkovito pri zmanjševanju kliničnih znakov, lezij in ponovne bakteriološke izolacije, povezanih z eksperimentalnimi okužbami z E. coli in/ali M. gallisepticum pri piščancih; čeprav je bil delež ponovne izolacije bakterij velik, zmanjšanje pri E. coli ni bilo statistično pomembno, vrednosti MIK za kužne seve pa so bile v primerjavi z večino sevov na terenu majhne.
Resistance to lincomycin can readily develop in B. hyodysenteriae and most of the isolates studied show decreased susceptibility in vitro. 
Odpornost na linkomicin se lahko pri B. Hyodysenteriae razvije hitro in večina preučevanih izolatov kaže in vitro zmanjšano občutljivost.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION To be completed nationally. 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Podatke je treba dopolniti v posameznih državah.
Repeated dosing of pigs with daily oral doses of 22 mg lincomycin/kg body weight for 3 days indicated no accumulation of lincomycin in the species, with no detectable serum levels of antibiotic after 24 hours post administration. 
Večkratno odmerjanje z dnevnimi odmerki 22 mg linkomicina/kg telesne teže prašičem 3 dni, je pokazalo da se linkomicin pri živalih ne kopiči; koncentracij antibitoka v serumu ni bilo mogoče izmeriti po 24 urah, po dajanju.
Meat and offal: 5 days. 
Meso in organi: 5 dni.
Co. Cork 
Ringaskiddy, Co. Cork,
In E. coli and Salmonella spp. 
Kaže, da je porazdelitev minimalnih inhibitornih koncentracij (MIK) pri E. coli in Salmonella spp.
“For the treatment and prevention of chronic respiratory disease (CRD) caused by Mycoplasma gallisepticum and Escherichia coli, and associated with a low mortality rate. 
„Za zdravljenje in preprečevanje kronične respiratorne bolezni (KRB), ki jo povzročata Mycoplasma gallisepticum ter Escherichia coli in je povezana z majhnim deležem umrljivosti.
Lincomycin is a lincosamide antibiotic derived from Streptomyces lincolnensis which inhibits protein synthesis. 
Linkomicin je antibiotik iz skupine linkozamidov in je proizvod bakterije Streptomyces lincolnensis, ki zavira sintezo breljakovin.
White HDPE bottle containing 150 g or 1.5 kg powder for oral solution with a white tamper evident LDPE lid. 
Bela HDPE plastenka z zaščitnim belim LDPE pokrovom vsebuje 150 g ali 1,5 kg praška za peroralno raztopino.
2,000 x [daily water consumption per bird (L)] average body weight of one bird (kg) 
2000 x [dnevno popita voda na žival (L)]
Lincomycin is active against gram-positive bacteria, some anaerobic gram-negative bacteria (such as Brachyspira hyodysenteriae) and mycoplasmas. 
Linkomicin deluje proti grampozitivnim bakterijam (kot je Brachyspira hyodysenteriae) in mikoplazmam.
MARKETING AUTHORISATION NUMBER(S) To be completed nationally 
ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET Podatke je treba dopolniti v posameznih državah
In a newly provided GCP-compliant challenge study the product used at 50 mg/kg/day for 7 days was shown to be effective in reducing clinical signs and lesions associated with E. coli and/or M. gallisepticum experimental infection in chickens, although the bacterial re-isolation rate was high - and its reduction was non statistically significant for E. coli - and the MIC values of the infective strains were at the very lower end of the range determined in the MIC surveys. 
V novo predloženi, z DKP skladni provokacijski študiji zdravljenja z zdravilom v odmerku 50 mg/kg telesne mase/dan, ki je trajalo 7 dni, so pokazali, da je učinkovito pri zmanjševanju kliničnih znakov in lezij, povezanih z eksperimentalnimi okužbami z E. coli in/ali M. gallisepticum pri piščancih, čeprav je bil delež ponovne izolacije bakterije velik (zmanjšanje pri E. coli ni bilo statistično pomembno), vrednosti MIK za kužne seve pa so bile povsem na spodnji meji razpona, določenega v raziskavah MIK.
SPECIAL WARNING(S) 
POSEBN(O)A OPOZORIL(O)A
Due to technical constraints the susceptibility of L. intracellularis is difficult to test in vitro, and data about the lincomycin-spectinomycin resistance status in that species are lacking. 
Zaradi tehničnih omejitev je občutljivost L. Intracellularis težko preskušati in vitro in zato so podatki o odpornosti na kombinacijo linkomicin - spektinomicin pri teh živalskih vrstah pomanjkljivi.
Pigs Poultry 
Prašiči Perutnina
In the new MIC survey using 25 isolates from Belgium, a lincomycinspectinomycin MIC range of 1:2 to 32:64 µg/ml was obtained, with a MIC50 of 16:32 and a MIC90 of 32:64 µg/ml. 
V novi raziskavi MIK, v kateri so uporabili 25 izolatov iz Belgije, so ugotovili razpon MIK linkomicina-spektinomicina od 1 : 2 do 32 : 64 µg/ml, pri čemer sta bili vrednosti MIK50
Lay: 
Serija:
Cases of diarrhoea or soft faeces and/or perianal region inflammation have been encountered in healthy pigs at the start of treatment. 
NEŽELENI UČINKI Pri zdravih prašičih se lahko na začetku zdravljenja pojavi prehodna driska ali mehko blato in/ali edem v perianalnem predelu.
PHARMACEUTICAL FORM Powder for use in drinking water. 
FARMACEVTSKA OBLIKA Prašek za uporabo v pitni vodi.
In chickens treated at several times the recommended dose, enlargement of the caecum and abnormal caecum content was observed. 
Pri piščancih so ob dajanju nekajkrat večjih odmerkov od priporočenih opazili nenavadno vsebino v cekumu in njegovo povečanje.
The presence of the disease in the flock must be established before the product is used.” 
Pred uporabo zdravila je treba potrditi prisotnost bolezni v jati.«
This study is the only formal demonstration of the benefit of the 50 mg/kg bw dose, and the obtained challenge was only mild to moderate, with no observed mortality. 
Ta študija je edini uradni dokaz za korist odmerka 50 mg/kg telesne mase, posledična provokacija pa je bila samo od blaga do zmerna, brez opažene umrljivosti.
This study was the only formal demonstration of the benefit of the 50 mg/kg bw dose, and the obtained challenge was only mild to moderate, with no observed mortality. 
Ta študija je bila edini uradni dokaz za korist odmerka 50 mg/kg telesne mase, posledična provokacija pa je bila samo od blaga do zmerna, brez opažene umrljivosti.
Likewise, information about the lack of data on the development of resistance in L. intracellularis should be included in the above mentioned sections of the SPC. 
V zgornji poglavji povzetka glavnih značilnosti zdravila je treba vključiti tudi informacije o pomanjkljivih podatkih o razvoju odpornosti L. intracellularis.
Zoetis Portugal, Lda Lagoas Park, Edifício 10 2740-271 Porto Salvo Portugal 
Portugalska Zoetis Portugal, Lda Lagoas Park, Edifício 10
PHARMACEUTICAL FORM Powder for use in drinking water 
FARMACEVTSKA OBLIKA Prašek za uporabo v vodi za pitje
Slovenia Zoetis Belgium SA, Rue Laid Burniat 1, 1348 Louvain-la-Neuve Belgium 
Zoetis Belgium SA, Rue Laid Burniat 1, 1348 Louvain-la-Neuve Belgija
Germany Zoetis Deutschland GmbH Schellingstraße 1, 
Zoetis Deutschland GmbH Schellingstraße 1, D-10785 Berlin Nemčija
As an indication, standard water intake varies around 0.15 L/kg bw/day. 
Običajna količina dnevno popite vode se giblje okrog 0,15 L/kg telesne teže/dan.
INDICATION(S) 
INDIKACIJ(A)E
Nevertheless, a clear warning as to the possibility of treatment failure due to clinically resistant strains in B. hyodysenteriae and associated Enterobacteriaceae (E. coli) should be included in section 4.4. 
Vendar je treba v poglavje 4.4 Posebna opozorila za vsako ciljno živalsko vrsto v povzetku glavnih značilnosti zdravila vključiti jasno opozorilo glede morebitno neuspešnega zdravljenja zaradi klinično odpornih sevov B. hyodysenteriae in sorodnih enterobakterij (E. coli).
PACKAGE LEAFLET FOR: <Invented name> 222 mg/g + 444.7 mg/g powder for use in drinking water for pigs and chickens 
<Izmišljeno ime> 222 mg/g + 444,7 mg/g prašek za dajanje v vodo za pitje za prašiče in piščance
Pigs: Meat and offal: Zero days. 
Prašiči: Meso in organi: nič dni.
It has little or no action against gram-negative bacteria such as Escherichia coli. 
Na gramnegativne bakterije kot je Escherichia coli deluje šibko ali nič.
The veterinary medicinal product should be used based on antimicrobial susceptibility testing. 
Uporaba zdravila mora temeljiti na preskušanju občutljivosti bakterij, ki se jih izolira iz živali.
The combination was shown to be superior to lincomycin alone. 
Pokazali so, da je kombinacija boljša kot monoterapija z linkomicinom.
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED To be completed nationally. 
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO Podatke je treba dopolniti v posameznih državah.
This benefit-risk evaluation is performed in the context of Article 34 of Directive 2001/82/EC, which in the present procedure has the purpose of obtaining harmonisation within the EU of the conditions of authorisation for the product Linco-Spectin 100 (and associated names). 
Njen namen v sklopu trenutnega postopka je uskladitev pogojev dovoljenj za promet z zdravilom LincoSpectin 100 (in povezanimi imeni) znotraj EU.
Linco-Spectin 100 is a powder for oral solution containing 33.3 g lincomycin (as lincomycin hydrochloride) and 66.7 g spectinomycin (as spectinomycin sulphate) per 150 g pack. 
Zdravilo Linco-Spectin 100 je prašek za peroralno raztopino, ki vsebuje 33,3 g linkomicina (v obliki linkomicinijevega hidroklorida) in 66,7 g spektinomicina (v obliki spektinomicinijevega sulfata) na pakiranje 150 g. Linkomicin je linkozamidni antibiotik, zelo podoben makrolidnim antibiotikom in streptograminom B. Zavira sintezo beljakovin, tako da se veže na ribosomsko podenoto bakterije 50S.
This amounts to 75 mg powder/kg bw/day for 7 days. 
To znese 75 mg praška na kg telesne teže na dan, za čas zdravljenja 7 dni.
Lincomycin and spectinomycin were shown to be more effective than each individual substance. 
Pokazali so, da je kombinacija linkomicina in spektinomicina učinkovitejša kot njuni monoterapiji.
A single oral dose of 10 mg/kg body weight was administered to pigs to determine the bioavailability. 
Za določitev biološke razpoložljivosti zdravila so prašičem dali enkratni peroralni odmerek 10 mg/kg telesne teže.
Pharmacotherapeutic group: antibacterials for systemic use, lincomycin combinations. 
Farmakoterapevtska skupina: zdravila za sistemsko zdravljenje bakterijskih infekcij, kombinacije linkomicina oznaka ATC vet: QJ01FF52
For use in drinking water. 
ZDRAVILA Za uporabo v vodi za pitje.
Ingestion by these species may result in severe gastrointestinal effects. 
Zaužitje lahko pri teh živalskih vrstah povzroči resne učinke na želodec in črevesje.
To determine the volume of dilution (in litres of drinking water) required for 150 g of the veterinary medicinal product, use the following formula: 
Piščanci: Za določitev volumna raztopine (v litrih vode za pitje), ki je potreben za 150 g zdravila za uporabo v veterinarski medicini, uporabite naslednjo formulo: Volumen (L) za 150 g zdravila za uporabo v veterinarski medicini
Oral powder for use in drinking water 
Peroralni prašek za uporabo v vodi za pitje
Pigs: for administration via drinking water. 
Prašiči: za dajanje v vodo za pitje.
2,500 L of drinking water 
2500 L vode za pitje
Lincomycin (as lincomycin hydrochloride) 
linkomicin (kot linkomicinijev klorid)
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary 
4.10 Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) V primeru prevelikega odmerjanja se pri prašičih lahko opazi spremenjeno konzistenco blata (mehko blato in/ali drisko).
This amounts to 15 mg powder/kg bw/day for 7 days. 
To znese 15 mg praška na kg telesne teže na dan, za čas zdravljenja 7 dni.
MARKETING AUTHORISATION HOLDER To be completed nationally. 
IMETNIK DOVOLJENJA ZA PROMET Podatke je treba dopolniti v posameznih državah.
In the event of overdose in pigs, a change in the consistency of the faeces (soft faeces and/or diarrhoea) may be observed. 
Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) (če je potrebno) V primeru prevelikega odmerjanja se pri prašičih lahko opazi spremenjeno konzistenco blata (mehko blato in/ali drisko).
Therefore, even though no evolution over time appears from the provided literature data, it cannot be excluded that the results obtained in the old clinical studies conducted at the time of product development do not reflect clinical efficacy in modern outbreaks of swine dysentery. 
Zato ni mogoče izključiti, da rezultati iz starih kliničnih študij, izvedenih v času razvoja zdravila, ne odražajo klinične učinkovitosti pri sodobnih izbruhih prašičje dizenterije, čeprav predloženi podatki iz literature ne kažejo na evolucijo v času.
Pharmacokinetic particulars 
Farmakokinetični podatki
The combination lincomycin-spectinomycin was also shown to be superior to each individual active substance. 
Pokazali so tudi, da je kombinacija linkomicina in spektinomicina boljša v primerjavi s posameznima zdravilnima učinkovinama.
Poultry, not eggs for human consumptio n oral 
Peroralni prašek Prašiči Perutnina, jajca niso za prehrano ljudi
The presence of the disease in the flock must be established before the product is used. 
Pred uporabo zdravila je treba potrditi prisotnost bolezni v čredi.
Soluble Powder Pigs Poultry (nonlayers) 
Topni prašek Prašiči in perutnina (nenesnice)
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Bottles containing 150 g or 1.5 kg and tub containing 4.5 kg 
Plastenke s 150 g ali 1,5 kg in vedro s 4,5 kg praška
Although the mechanism of action at the systemic level of spectinomycin administered orally is not elucidated, its clinical benefit and the benefit of the combination seems to be demonstrated in several older laboratory challenge studies; however, the dosing regimens applied in these studies can only be estimated and likely range from the harmonised dose of 50 mg/kg bw/day to at least the highest approved dose of 150 mg/kg bw/day. 
Vendar je mogoče režime odmerjanja, uporabljene v teh študijah, samo oceniti: njihov razpon je verjetno od usklajenega odmerka 50 mg/kg telesne mase/dan in vsaj do največjega odobrenega odmerka 150 mg/kg telesne mase/dan.
Ask your veterinary surgeon how to dispose of medicines no longer required. 
ZDRAVILA ALI ODPADNIH SNOVI, ČE OBSTAJAJO Glede odstranjevanja zdravil, ki jih ne uporabljate več, se posvetujte z veterinarjem.
The spectinomycin exhibits little tendency to protein binding and is poorly liposoluble. 
Spektinomicin se v majhni meri veže na plazemske beljakovine in je slabo topen v maščobah.
Pigs Chicken (broiler, pullet) Turkey 
Peroralni prašek Prašiči Perutnina (brojlerji, kokoši in purani)
Meat and offal: Zero days. 
Meso in organi: nič dni.
To ensure a correct dosage and avoid underdosing, mean body weights in the group of animals and daily water consumption should be determined as accurately as possible. 
Čim natančneje je treba določiti povprečno telesno težo živali v čredi/jati in količino dnevno popite vode, da se zagotovi pravilen odmerek in da se izognemo premajhnemu odmerjanju.
Chickens 
Ciper
- very rare (less than 1 animal in 10,000 animals, including isolated reports). 
- občasni (pri več kot 1 a manj kot 10 živali od 1.000 živali) - redki (pri več kot 1 a manj kot 10 živali od 10.000 živali) - zelo redki (pri manj kot 1 živali od 10.000 živali, vključujoč posamezne primere).
0.2 L/kg bw/day 
0.2 L/kg telesne teže/dan
1,000 L of drinking water 
1000 L vode za pitje
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) 
Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (pri več kot 1 živali od 10 živali med enim ciklom zdravljenja)
Marketing authorisation holder and manufacturer responsible for batch release: To be completed nationally 
Izdelovalec, odgovoren za sproščanje serije:
1,500 L of drinking water 
1500 L vode za pitje
0.1 L/kg bw/day 
0.1 L/kg telesne teže/dan
Powder for solution in drinking water 
Prašek za raztopino v vodi za pitje
2,000 L of drinking water 
2000 L vode za pitje
Soluble powder Pigs Chickens 
Topni prašek Prašiči Piščanci
EXPIRY DATE 
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP
0.25 L/kg bw/day 
0.25 L/kg telesne teže/dan